Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Research and Markets
DUBLIN, February 11, 2014 /PRNewswire/ --
Dublin - Research and Markets (http://www.researchandmarkets.com/research/nmjj46/microneedle_drug) has announced the addition of the "Microneedle Drug Delivery Systems to 2018" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
Microneedle technology is attaining commercial viability at a time when drug developers are faced with new challenges as they assess ways to administer new classes of compounds with significant therapeutic potential. The widespread availability of rapid throughput screening is accelerating the discovery of new drugs, a significant number of which are large-molecule therapeutic compounds that cannot tolerate passage through the digestive system, requiring pharmaceutical companies to forego oral formulations and select alternate routes of administration.
Key Topics Covered:
Microneedle Medical Market Overview
Drug Delivery & Self-Administration
Chronic Conditions & Dosing Frequency
Patient Safety and Compliance
Microneedle Market Drivers
The Trend to Minimally Invasive Medicine
Shifting Patient Demographics
Managed Care Initiatives
Government Technology Transfer Programs
Microneedle Design & Technology
Microneedle Form Factors
Microneedle Arrays & Array Geometries
Material Selection Issues
Emerging Fabrication Methods
Medical Microneedles - Assessments & Commercialization Prospects
Solid Microneedle Arrays
Hollow Microneedle Arrays
Phase Transition Microneedle Patch
Dissolving Microneedle Chip
Syringe Mounted Microneedles
Programmable Microneedle Patch
Near-Terms Markets - Sector Assessments and Forecasts
For more information visit http://www.researchandmarkets.com/research/nmjj46/microneedle_drug
Media Contact: Laura Wood , +353-1-481-1716, firstname.lastname@example.org
©2012 PR Newswire. All Rights Reserved.